Clinical TrialsSearch results for "cytarabine"
Number of results: 449
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12
Recruiting
- JALSG-AML224-PIF
- AML patients who do not achieve complete remission after a single course of induction chemotherapy
- Kiyoi Hitoshi
- 2025-08-12